Christopher Dinsmore - 15 Feb 2022 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role
Chief Scientific Officer
Signature
/s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol
KRON
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4
Filing time
17 Feb 2022, 16:21:13 UTC
Previous filing
15 Dec 2021
Next filing
27 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRON Common Stock Award $0 +43,550 +51% $0.000000 128,524 15 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRON Employee Stock Option (Right to Buy) Award $0 +65,000 $0.000000 65,000 15 Feb 2022 Common Stock 65,000 $7.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.